The molecular docking study confirms the same results obtained by Koshak et al. 2021 [60] which suggest that TQ can act against COVID-19 by inhibiting the angiotensin-converting enzyme 2 (ACE2) which inhibits the interaction of viral proteins. This evidence concerns the gene ACE2 and COVID-19.